tiprankstipranks
Thirumalai Chemicals Limited (IN:TIRUMALCHM)
:TIRUMALCHM
India Market
Want to see IN:TIRUMALCHM full AI Analyst Report?

Thirumalai Chemicals Limited (TIRUMALCHM) AI Stock Analysis

3 Followers

Top Page

IN:TIRUMALCHM

Thirumalai Chemicals Limited

(TIRUMALCHM)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
₹199.00
▼(-15.03% Downside)
Action:ReiteratedDate:03/19/26
The score is primarily held down by weak financial performance—declining revenue, recent losses, and negative operating/free cash flow—along with a technically weak setup (below key moving averages and negative MACD). Valuation is only slightly supportive because the negative P/E is driven by losses and dividend yield data is unavailable.
Positive Factors
Diversified end‑market exposure
Thirumalai supplies intermediates used across multiple end markets (plastics, coatings, F&B, pharma). This structural diversification reduces reliance on any single cyclical industry, helping stabilize volumes and revenue over a multi‑month horizon and supporting resilience through sector-specific downticks.
Negative Factors
Sustained revenue decline
Revenue has declined materially over recent years, indicating either weakening demand, pricing pressure, or market share loss. Restoring top‑line scale is typically slow in chemical markets; prolonged revenue decline will continue to pressure fixed‑cost absorption, margins, and the company’s ability to invest in higher‑value initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified end‑market exposure
Thirumalai supplies intermediates used across multiple end markets (plastics, coatings, F&B, pharma). This structural diversification reduces reliance on any single cyclical industry, helping stabilize volumes and revenue over a multi‑month horizon and supporting resilience through sector-specific downticks.
Read all positive factors

Thirumalai Chemicals Limited (TIRUMALCHM) vs. iShares MSCI India ETF (INDA)

Thirumalai Chemicals Limited Business Overview & Revenue Model

Company Description
Thirumalai Chemicals Limited manufactures and sells organic chemicals in India. It offers phthalic anhydride, maleic anhydride, malic acid, fumaric acid, and diethyl phthalate; and generates power from wind operated generators, as well as engineer...
How the Company Makes Money
Thirumalai Chemicals makes money primarily by manufacturing and selling chemical intermediates and derivatives to industrial customers. Its key revenue streams typically come from (1) sales of phthalic anhydride, a high-volume intermediate used in...

Thirumalai Chemicals Limited Financial Statement Overview

Summary
Income statement weakness (revenue decline and negative net margins in 2024–2025) and cash flow deterioration (negative operating cash flow and negative free cash flow) outweigh a only moderate balance-sheet position with rising leverage.
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue18.65B20.50B20.72B21.20B19.97B10.85B
Gross Profit3.55B4.63B3.87B6.01B7.65B4.16B
EBITDA-280.65M488.00M645.40M2.16B4.52B2.28B
Net Income-1.49B-461.00M-387.90M898.30M2.81B1.18B
Balance Sheet
Total Assets43.45B38.07B33.20B23.60B18.62B13.43B
Cash, Cash Equivalents and Short-Term Investments3.70B1.86B4.49B4.59B5.54B3.25B
Total Debt20.86B17.86B12.52B5.14B1.65B1.83B
Total Liabilities28.12B26.51B21.74B11.68B7.77B5.40B
Stockholders Equity15.32B11.56B11.46B11.92B10.85B8.03B
Cash Flow
Free Cash Flow-6.28B-6.79B-5.74B-3.09B3.29B1.60B
Operating Cash Flow-2.68B-658.80M2.37B541.30M4.02B2.21B
Investing Cash Flow-3.50B-5.42B-8.31B-3.59B-1.39B-1.57B
Financing Cash Flow6.18B3.75B6.43B2.06B-699.80M-379.70M

Thirumalai Chemicals Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price234.20
Price Trends
50DMA
186.71
Positive
100DMA
205.60
Negative
200DMA
247.65
Negative
Market Momentum
MACD
3.78
Negative
RSI
61.92
Neutral
STOCH
93.50
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TIRUMALCHM, the sentiment is Neutral. The current price of 234.2 is above the 20-day moving average (MA) of 179.49, above the 50-day MA of 186.71, and below the 200-day MA of 247.65, indicating a neutral trend. The MACD of 3.78 indicates Negative momentum. The RSI at 61.92 is Neutral, neither overbought nor oversold. The STOCH value of 93.50 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:TIRUMALCHM.

Thirumalai Chemicals Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
₹26.75B23.710.65%2.07%-16.12%
66
Neutral
₹13.20B-28.192.59%-17.51%-106.98%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
₹27.65B29.380.97%8.37%19.15%
56
Neutral
₹14.39B26.880.24%14.39%75.07%
53
Neutral
₹30.62B51.390.07%28.53%129.16%
45
Neutral
₹24.59B-15.050.43%-11.11%-340.74%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:TIRUMALCHM
Thirumalai Chemicals Limited
203.95
-43.45
-17.56%
IN:FCL
Fineotex Chemical Limited
22.97
-1.47
-6.01%
IN:IGPL
IG Petrochemicals Ltd.
428.75
9.13
2.18%
IN:IOLCP
IOL Chemicals & Pharmaceuticals Ltd.
94.20
30.07
46.89%
IN:PUNJABCHEM
Punjab Chemicals & Crop Protection Ltd.
1,173.60
100.79
9.39%
IN:TATVA
Tatva Chintan Pharma Chem Limited
1,308.95
601.25
84.96%

Thirumalai Chemicals Limited Corporate Events

Thirumalai Chemicals Schedules Institutional Investor Meeting for March 9
Mar 4, 2026
Thirumalai Chemicals Limited has announced that its officials will hold a group meeting with existing and prospective institutional investors on March 9, 2026. The company has made its latest investor presentation publicly available on its website...
Thirumalai Chemicals Posts Q3 & Nine-Month FY26 Investor Presentation
Mar 3, 2026
Thirumalai Chemicals Limited has released its corporate presentation for the third quarter and nine months ended December 2025, providing an update on its financial and operating performance for FY26 to the stock exchanges. The presentation has be...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026